Systolic blood pressure does not reliably identify vasoactive status in chronic heart failure

American Journal of Hypertension

Volumn 18, Issue 2 SUPPL., 2005, Pages 82-86

  Parrott, Charles W ^a   Quale, Cheryl ^a   Lewis, Deborah L ^a   Ferguson, Sara ^a   Brunt, Rhonda ^a   Glass, Susan ^a  

^a Providence Hospital Mobile   (United States)

Author keywords

Heart failure; Hemodynamics; Hypertension; Impedance cardiography; Thoracic electrical bioimpedance; Vasoconstriction; Vasodilation

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART FAILURE; HUMAN; IMPEDANCE CARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OSCILLOMETRY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION;

EID: 14744298691     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.11.024     Document Type: Article

References (23)

1. S. Sharma, D. Deitchman, J.S. Eni, K. Gelperin, J.P. Ilgenfritz, M. Blumenthal Fosinopril Hemodynamics Study Group The hemodynamic effects of long-term ACE inhibition with fosinopril in patients with heart failure Am J Ther 6 1999 181 189
2. A.E. Steimle, L.W. Stevenson, C. Chelimsky-Fallick, G.C. Fonarow, M.A. Hamilton, J.D. Moriguchi, A. Kartashov, J.H. Tillisch Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure Circulation 96 1997 1165 1172
3. C. Yancy, W. Abraham Noninvasive hemodynamic monitoring in heart failure Utilization of impedance cardiography Congest Heart Fail 9 2003 241 250
4. B.H. Greenberg, D.D. Hermann, M.F. Pranulis, L. Lazio, D. Cloutier Reproducibility of impedance cardiography hemodynamic measures in clinically stable heart failure patients Congest Heart Fail 6 2000 19 26
5. M. Drazner, B. Thompson, P. Rosenberg, C. Yancy Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy Am J Cardiol 89 2002 993 995
6. N.M. Albert, M.D. Hail, J. Li, J.B. Young Equivalence of bioimpedance and thermodilution in measuring cardiac output in hospitalized patients with advanced, decompensated chronic heart failure Am J Crit Care 13 2004 469 479
7. BioZ ICG Monitor Operator Manual 2004 CardioDynamics San Diego
8. D.L. Clement, M. De Buyzere, D. Duprez Left ventricular function and regression of left ventricular hypertrophy in essential hypertension Am J Hypertens 6 1993 14S 19S
9. B.H. Greenberg Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials J Cardiol Fail 8 6 Suppl 2002 S486 S490
10. R. Summers, C. Parrott, C. Quale, D. Lewis Use of in noninvasive hemodynamics to aid decision making in the initiation and titration of neurohormonal agents Congest Heart Fail 10 Suppl 2 2004 28 31
11. G. Piccirillo, R.L. Luparini, V. Celli, A. Moise, M. Lionetti, V. Marigliano, M. Cacciafesta Effects of carvedilol on heart rate and blood pressure variability in subjects with chronic heart failure Am J Cardiol 86 2000 1392 1395
12. F.A. Masoudi, S.S. Rathore, Y. Wang, E.P. Havranek, J.P. Curtis, J.M. Foody, H.M. Krumholz National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction Circulation 110 2004 724 731
13. C. Rangaswamy, J.I. Finn, T.M. Koelling Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction Cardiology 103 2004 17 23
14. M. Packer, P.A. Poole-Wilson, P.W. Armstrong, J.G. Cleland, J.D. Horowitz, B.M. Massie, L. Ryden, K. Thygesen, B.F. Uretsky ATLAS Study Group Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure Circulation 100 1999 2312 2318
15. S.R. Majumdar, F.A. McAlister, M. Cree, W.C. Chang, M. Packer, P.W. Armstrong ATLAS Study Group Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study Clin Ther 26 2004 694 703
16. J.S. Taylor, G.R. Ellis Racial differences in responses to drug treatment implications for pharmacotherapy of heart failure Am J Cardiovasc Drugs 2 2002 389 399
17. A.L. Taylor, S. Ziesche, C. Yancy, P. Carson, R. D'Agostino Jr, K. Ferdinand, M. Taylor, K. Adams, M. Sabolinski, M. Worcel, J.N. Cohn Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
18. M. Packer, J. Meller, N. Medina, R. Gorlin, M.V. Herman Hemodynamic evaluation of hydralazine dosage in refractory heart failure Clin Pharmacol Ther 27 1980 337 346
19. K. Ueda, M. Sakai, S. Matsushita, I. Kuwajima, M. Murakami Effect of orally administered hydralazine on neurohumoral factors and hemodynamic response in aged patients with chronic congestive heart failure Jpn Heart J 24 1983 711 721
20. A.L. Hinderliter, J.A. Blumenthal, R. Waugh, M. Chilukuri, A. Sherwood Ethnic differences in left ventricular structure relations to hemodynamics and diurnal blood pressure variation Am J Hypertens 17 2004 43 49
21. C.N. Gring, G.S. Francis A hard look at angiotensin receptor blockers in heart failure J Am Coll Cardiol 44 2004 1841 1846
22. B.M. Massie, P.W. Armstrong, J.G. Cleland, J.D. Horowitz, M. Packer, P.A. Poole-Wilson, L. Ryden Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival Arch Intern Med 161 2001 165 171
23. J.N. Cohn Heart failure future treatment approaches Am J Hypertens 13 2000 74S 78S